Global Bioenergies lists on NYSE Alternext

Back

NYSE Euronext today announced the listing on NYSE Alternext in Paris of Global Bioenergies, a company specialized in bioprocesses that convert renewable resources into hydrocarbons.

Founded in 2008, Global Bioenergies is developing a unique process to produce isobutene biologically from renewable resources. Isobutene, a hydrocarbon currently obtained exclusively from fossil oil, is one of the key building blocks of the petrochemical industry. It can be used to produce each of the three main fuels - gasoline, diesel and kerosene - as well as a wide range of other materials (synthetic rubber, organic glass and plastics). Global Bioenergies is a French company based in Evry, south of Paris, and employs a staff of around 20 that is primarily involved in R&D.

Global Bioenergies (ticker code: ALGBE) was listed through admission to trading of 1,246,500 existing shares and 333,675 new shares and additional new shares issued under a Global Offering[1], including full exercise of the extension clause and over-allotment option. The Global Offering raised a total of €6.6 million, including full exercise of the extension clause and over-allotment option.

The admission and issue price of Global Bioenergies shares was set at €19.85. Market capitalization stood at €31.4 million on the day of listing.

Press Release

Press Release Footer

About Euronext 
Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway and Portugal.
As of September 2025, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal host over 1,700 listed issuers with €6.5 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 25% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices.
In November 2025, Euronext successfully acquired a majority stake in the Athens Stock Exchange (ATHEX), further expanding its footprint and strengthening its pan-European market infrastructure.

For the latest news and resources, please visit the Media Centre. 
Follow us on X (x.com/euronext) and LinkedIn (linkedin.com/company/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2025, Euronext N.V. - All rights reserved.